MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) ("MMJ") is pleased to attach a copy of a news release announcing that MediPharm Labs Inc ("MediPharm Labs") (CVE:LABS) has expandedits annual production capacity by 50 per cent.

MMJ owns approximately 4.4 million shares for a 4.5% shareholding and 2.9 million warrants (exercisable at CAD$1.20 per share by October 2020) in MediPharm Labs.

To view the release, please visit:
http://abnnewswire.net/lnk/S746C6P0


About MMJ Group Holdings Ltd

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

   

Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



Link: MediPharm Labs expands production capacity by 50 per cent



Related Companies

MMJ Group Holdings Ltd
  


Related Industry Topics:
Food & Beverage Medical Equipment Drugs & OTC Ag Biotechnology Consumers General Health & Pharm General